NickFi

CLRB going down?

Short
NickFi Aktualisiert   
NASDAQ:CLRB   Cellectar Biosciences, Inc.
CLRB has a buy rating on Zacks Rank, but it has poor financial. Based on my experience (or lack of) studying the graph, I expect the stock will drop in the future. At the moment the stock is $4.08.
Kommentar:
The stock briefly reached $4.76 before dropping to $4.11 in a matter of minutes. In the hindsight, I wish I took the trade
Kommentar:
I am puzzled because on tradingview the stock appears to have reached a peak of around $4.27, while on Interactive Brokers one minute chart, the peak was at $4.76. My idea for CLRB had the entry price at $4.77, which was very close to the entry price listed on IB. Maybe the transaction volume between $4.27 and $4.76 was very small.

Haftungsausschluss

Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.